Media Summary: At , Dr. Camidge offered thoughtful insights drawn from both his clinical expertise and personal experience. Hear from Co-Chair Ferdinando Cerciello on why you should join us in Dublin for the Dr. Karen Kelly, CEO of the International Association for the Study of Lung Cancer (

2026 Iaslc Targeted Therapies Of - Detailed Analysis & Overview

At , Dr. Camidge offered thoughtful insights drawn from both his clinical expertise and personal experience. Hear from Co-Chair Ferdinando Cerciello on why you should join us in Dublin for the Dr. Karen Kelly, CEO of the International Association for the Study of Lung Cancer ( Nicolas Girard, MD, PhD, Institut Curie, Paris, France, discusses the range of first-line EGFR- In this session from the Total Health 2023 Best of Lung conference, Dr Jaime Schneider from Massachusetts General Hospital ... Yale Cancer Center Grand Rounds February 17,

Dr. David Barbie provides an update on the

Photo Gallery

2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge
2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge
IASLC Insider's Corner Featuring Dr. Alex Adjei
Ferdinando Cerciello | IASLC 2026 Hot Topic Co-Chair
Lung Cancer Treatment Is Changing FAST — Here's What Doctors Learned at the 2026 TTLC Meeting
2026 Latest On Lupus Conference | Lupus Research, CAR T-Cell Therapy, Co-Conditions & Women’s Health
Next-Generation Immunotherapy: Emerging Science and New Approaches | KCRS 2026
How IASLC is changing the global fight against lung cancer | Karen Kelly at BGICC 2026
Optimal sequencing of EGFR-targeted therapies for NSCLC
2023 Best of Lung: Targeted Therapies in Lung Cancer
Small Cell Lung Cancer: Updates, Progress, and Promise of 'Targeted Therapy' | Dr. Anne Chiang
David Barbie's Discusses the IASLC-LCRF Team Science Research Grant
View Detailed Profile
2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge

2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge

At #TTLC26, Dr. Camidge offered thoughtful insights drawn from both his clinical expertise and personal experience.

2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge

2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge

At #TTLC26, Dr. Camidge offered thoughtful insights drawn from both his clinical expertise and personal experience.

IASLC Insider's Corner Featuring Dr. Alex Adjei

IASLC Insider's Corner Featuring Dr. Alex Adjei

Hear from Dr. Alex Adjei,

Ferdinando Cerciello | IASLC 2026 Hot Topic Co-Chair

Ferdinando Cerciello | IASLC 2026 Hot Topic Co-Chair

Hear from Co-Chair Ferdinando Cerciello on why you should join us in Dublin for the

Lung Cancer Treatment Is Changing FAST — Here's What Doctors Learned at the 2026 TTLC Meeting

Lung Cancer Treatment Is Changing FAST — Here's What Doctors Learned at the 2026 TTLC Meeting

The

2026 Latest On Lupus Conference | Lupus Research, CAR T-Cell Therapy, Co-Conditions & Women’s Health

2026 Latest On Lupus Conference | Lupus Research, CAR T-Cell Therapy, Co-Conditions & Women’s Health

Watch the full replay of Lupus LA's

Next-Generation Immunotherapy: Emerging Science and New Approaches | KCRS 2026

Next-Generation Immunotherapy: Emerging Science and New Approaches | KCRS 2026

Immunotherapy has transformed the

How IASLC is changing the global fight against lung cancer | Karen Kelly at BGICC 2026

How IASLC is changing the global fight against lung cancer | Karen Kelly at BGICC 2026

Dr. Karen Kelly, CEO of the International Association for the Study of Lung Cancer (

Optimal sequencing of EGFR-targeted therapies for NSCLC

Optimal sequencing of EGFR-targeted therapies for NSCLC

Nicolas Girard, MD, PhD, Institut Curie, Paris, France, discusses the range of first-line EGFR-

2023 Best of Lung: Targeted Therapies in Lung Cancer

2023 Best of Lung: Targeted Therapies in Lung Cancer

In this session from the Total Health 2023 Best of Lung conference, Dr Jaime Schneider from Massachusetts General Hospital ...

Small Cell Lung Cancer: Updates, Progress, and Promise of 'Targeted Therapy' | Dr. Anne Chiang

Small Cell Lung Cancer: Updates, Progress, and Promise of 'Targeted Therapy' | Dr. Anne Chiang

Yale Cancer Center Grand Rounds | February 17,

David Barbie's Discusses the IASLC-LCRF Team Science Research Grant

David Barbie's Discusses the IASLC-LCRF Team Science Research Grant

Dr. David Barbie provides an update on the

ELCC 2026: TOP Study, Sac-TMT, and the Future of EGFR-Mutant NSCLC

ELCC 2026: TOP Study, Sac-TMT, and the Future of EGFR-Mutant NSCLC

The